Sign in or create an account to add this stock to your watchlist.
About Aemetis (NASDAQ:AMTX)
Aemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol plant in the California Central Valley near Modesto; and a biodiesel plant in Kakinada, India. The company sells biodiesel and refined glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers soluble or corn syrup products to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
Industry, Sector and Symbol
Industry Industrial organic chemicals
Sub-IndustryN/A
SectorOils/Energy
SymbolNASDAQ:AMTX
CUSIPN/A
Phone408-517-3304
Debt
Debt-to-Equity Ratio-1.40
Current Ratio0.20
Quick Ratio0.09
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$150.15 million
Price / Sales0.23
Cash FlowN/A
Price / CashN/A
Book Value($4.49) per share
Price / Book-0.38
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-30,300,000.00
Net Margins-19.89%
Return on EquityN/A
Return on Assets-37.74%
Miscellaneous
Employees140
Outstanding Shares20,220,000
Aemetis (NASDAQ:AMTX) Frequently Asked Questions
What is Aemetis' stock symbol?
Aemetis trades on the NASDAQ under the ticker symbol "AMTX."
How were Aemetis' earnings last quarter?
Aemetis Inc (NASDAQ:AMTX) issued its quarterly earnings data on Monday, November, 14th. The specialty chemicals company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.06. The specialty chemicals company had revenue of $39.38 million for the quarter, compared to analysts' expectations of $37.75 million. View Aemetis' Earnings History.
What price target have analysts set for AMTX?
3 equities research analysts have issued 1 year target prices for Aemetis' stock. Their predictions range from $2.00 to $2.00. On average, they anticipate Aemetis' stock price to reach $2.00 in the next year. View Analyst Ratings for Aemetis.
Are investors shorting Aemetis?
Aemetis saw a decline in short interest in the month of April. As of April 13th, there was short interest totalling 348,149 shares, a decline of 41.0% from the March 30th total of 589,751 shares. Based on an average daily trading volume, of 253,596 shares, the days-to-cover ratio is currently 1.4 days. Approximately 2.4% of the shares of the stock are sold short.
Who are some of Aemetis' key competitors?
Who are Aemetis' key executives?
Aemetis' management team includes the folowing people:
- Mr. Eric A. McAfee, Co-Founder, Exec. Chairman, CEO & Pres (Age 55)
- Mr. Todd A. Waltz, Exec. VP, CFO & Sec. (Age 57)
- Mr. Andrew B. Foster, Exec. VP & COO (Age 53)
- Mr. Sanjeev Gupta, EVP & Pres (Age 58)
Has Aemetis been receiving favorable news coverage?
News articles about AMTX stock have been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aemetis earned a coverage optimism score of 0.07 on Accern's scale. They also gave media headlines about the specialty chemicals company an impact score of 47.21 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Aemetis?
Shares of AMTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aemetis' stock price today?
One share of AMTX stock can currently be purchased for approximately $1.69.
How big of a company is Aemetis?
Aemetis has a market capitalization of $34.78 million and generates $150.15 million in revenue each year. Aemetis employs 140 workers across the globe.
How can I contact Aemetis?
Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The specialty chemicals company can be reached via phone at 408-517-3304 or via email at [email protected]
MarketBeat Community Rating for Aemetis (AMTX)
MarketBeat's community ratings are surveys of what our community members think about Aemetis and other stocks. Vote "Outperform" if you believe AMTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Aemetis (NASDAQ:AMTX) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Aemetis in the last 12 months. Their average twelve-month price target is $2.00, suggesting that the stock has a possible upside of 18.34%. The high price target for AMTX is $2.00 and the low price target for AMTX is $2.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.33 | 2.33 | 2.00 | 2.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $2.00 | $2.00 | $2.00 | $2.00 |
| Price Target Upside: | 18.34% upside | 9.09% downside | 159.74% upside | 159.74% upside |
Aemetis (NASDAQ:AMTX) Consensus Price Target History
Aemetis (NASDAQ:AMTX) Analyst Ratings History
Show:
(Data available from 5/24/2016 forward)
Aemetis (NASDAQ:AMTX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Aemetis (NASDAQ AMTX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 24.16%
Institutional Ownership Percentage: 16.65%
Aemetis (NASDAQ AMTX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/15/2017 | Lydia I Beebe | Director | Buy | 10,000 | $1.28 | $12,800.00 | 10,000 |  |
| 10/4/2013 | Eric A Mcafee | CEO | Sell | 500,000 | $0.30 | $150,000.00 | | |
| 5/9/2013 | Eric A Mcafee | CEO | Sell | 222,222 | $0.45 | $99,999.90 | | |
| 12/11/2012 | Francis P Barton | Director | Buy | 50,000 | $0.43 | $21,500.00 | | |
| 10/24/2012 | Francis P Barton | Director | Buy | 100,000 | $0.58 | $58,000.00 | | |
(Data available from 1/1/2013 forward)
Aemetis (NASDAQ AMTX) News Headlines
| Source: |
|
Aemetis (NASDAQ:AMTX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Aemetis (NASDAQ:AMTX) Income Statement, Balance Sheet and Cash Flow Statement
Aemetis (NASDAQ AMTX) Stock Chart for Thursday, May, 24, 2018
Loading chart…
